ZIOPHARM Oncology Inc (ZIOP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

ONE FIRST AVENUE BOSTON, MA 02129

ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs. The Company is conducting U.S. studies for its two product candidates, ZIO-101 and ZIO-201.

Data based on most recent fiscal year report
Market Cap807.394 Million Shares Outstanding181.03 Million Avg Volume2.286 Million
1-Yr BETA vs S&P TR1.226 Current Ratio8.89 Quick Ratio8.89
View SEC Filings from ZIOP instead.

View recent insider trading info

Funds Holding ZIOP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZIOP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KIRK RANDAL J EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
80,237,775 2020-03-19 0

LEBEL FRANCOIS CHIEF MEDICAL OFFICER

  • Officer
311,678 2020-03-12 0

SCHWARTZ BRIAN

  • Director
6,000 2020-03-05 0

AMELLO JASON SVP, CFO & TREASURER

144,642 2020-02-28 0

BOWDEN CHRISTOPHER CHIEF MEDICAL OFFICER

  • Officer
5,318 2020-02-22 3

ABERCROMBIE GEORGE B CHIEF EXECUTIVE OFFICER

138,424 2020-02-14 0

LAFOND KEVIN G SVP, TREASURER & CAO

  • Officer
81,985 2020-01-29 3

COOPER LAURENCE JAMES NEIL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,904,973 2020-01-29 2

MAUNEY DAVID M MD PRESIDENT

  • Officer
275,778 2020-01-29 2

HADFIELD ROBERT GENERAL COUNSEL AND SECRETARY

  • Officer
159,819 2020-01-29 2

DE GROOT ELEANOR EVP, GM CELL THERAPY

  • Officer
228,033 2020-01-29 3

BUCK JILL EVP, GM GENE THERAPY

  • Officer
227,410 2020-01-29 3

SHUKLA SATH EVP, CHIEF FINANCIAL OFFICER

  • Officer
80,500 2020-01-29 3

TARRIFF SCOTT CEO

  • Officer
  • Director
  • 10% Owner
1,550,954 2020-01-23 1

BRAUNSTEIN SCOTT

  • Director
26,500 2020-01-09 1

EZICKSON ELAN

  • Director
71,887 2019-12-31 1

PAGAN DOUGLAS W.

  • Director
35,943 2019-12-31 1

HAGEN HEIDI

  • Director
32,119 2019-12-31 3

KIRK RANDAL J

INTREXON CORP

  • 10% Owner
0 2019-12-13 0

WEISER MICHAEL

  • Director
0 2019-06-10 0

FOWLER WYCHE

  • Director
77,233 2019-05-22 0

CANNON JAMES ANTHONY

  • Director
398,050 2019-05-07 1

BELBEL CAESAR J COO, CLO, AND SECRETARY

  • Officer
207,434 2017-12-29 0

BRENNAN MURRAY

  • Director
72,620 2017-12-29 0

MCINERNEY TIMOTHY

  • Director
0 2017-05-18 0

YOUSSOUFIAN HAGOP CHIEF MEDICAL OFFICER

  • Officer
0 2015-03-07 0

LEWIS JONATHAN CEO

  • Officer
  • Director
744,145 2014-12-30 0

BAGLEY RICHARD E PRESIDENT, COO & TREASURER

  • Officer
  • Director
211,239 2011-12-30 0

FRAGIN GARY S

  • Director
67,500 2010-03-31 0

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

  • 10% Owner
2,371,642 2009-09-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments